User profiles for GIAN DOMENICO SEBASTIANI
Gian Domenico sebastianiAzienda Ospedaliera San Camillo - Forlanini Verified email at scamilloforlanini.rm.it Cited by 11102 |
Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
…, C Vasconcelos, D D'Cruz, GD Sebastiani… - Arthritis & …, 2002 - Wiley Online Library
Objective Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE)
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…
that is usually treated with an extended course of intravenous (IV) cyclophosphamide (…
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD SEBASTIANI… - Medicine, 1993 - journals.lww.com
Systemic Lupus Erythematosus: Clinical and Immunologic Patte... : Medicine Systemic Lupus
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …
Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients
R Cervera, MA Khamashta, J Font, GD Sebastiani… - Medicine, 1999 - journals.lww.com
… Divisione di Reumatologia, Ospedale San Camillo de Lellis, Rome, Italy: Gian Domenico
Sebastiani. Department of Immunology, Medical School of Ankara University, Ankara, Turkey: …
Sebastiani. Department of Immunology, Medical School of Ankara University, Ankara, Turkey: …
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis …
…, C Vasconcelos, D D'Cruz, GD Sebastiani… - Arthritis & …, 2004 - Wiley Online Library
Objective In the Euro‐Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …
randomly assigned to a high‐dose intravenous cyclophosphamide (IV CYC) regimen (6 …
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera, MA Khamashta, J Font, GD Sebastiani… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
…, C Vasconcelos, D D'Cruz, GD Sebastiani… - Annals of the …, 2010 - ard.bmj.com
Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised
prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) …
prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) …
miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis
V Fulci, G Scappucci, GD Sebastiani, C Giannitti… - Human immunology, 2010 - Elsevier
miRNAs have recently emerged as key regulators of the immune system, being involved in
lymphocyte selection and proliferation, in T reg cells differentiation, and in hematopoiesis in …
lymphocyte selection and proliferation, in T reg cells differentiation, and in hematopoiesis in …
[HTML][HTML] Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
…, V Riccieri, F Conti, GD Sebastiani… - Journal of clinical …, 2019 - mdpi.com
Antisynthetase syndrome (ASSD) is a rare clinical condition that is characterized by the
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …
occurrence of a classic clinical triad, encompassing myositis, arthritis, and interstitial lung …
Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis
…, B Serafini, B Rosicarelli, GD Sebastiani… - The Journal of …, 2004 - journals.aai.org
Dendritic cells (DCs) are thought to play a key role in driving the immunopathogenic response
underlying chronic inflammatory arthritis. In this study, we have examined the presence …
underlying chronic inflammatory arthritis. In this study, we have examined the presence …
[HTML][HTML] Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study
…, R Pullmann, J Ordi-Ros, GD Sebastiani… - Arthritis research & …, 2009 - Springer
Introduction We aimed to replicate association of newly identified systemic lupus erythematosus
(SLE) loci. Methods We selected the most associated SNP in 10 SLE loci. These 10 …
(SLE) loci. Methods We selected the most associated SNP in 10 SLE loci. These 10 …